Cold Chain

Latest project broadens capacity, cold chain services and technology

Association hopes to prep supply chain for one of its largest logistical challenges

Tool will help airports with coronavirus vaccine prep

Its unique storage requirements may pose challenges for inoculation programs

Product intelligence platform could help tackle supply chain issues sooner rather than later

Partnership could help diminish cold-chain challenges surrounding storage and handling

Report: Company, which has created its own "thermal shipper," will bypass CDC's recommended distributor

Signs deal with major cargo airline around its passive bulk temperature-controlled container

FCS Frankfurt Cargo Services receives EU pharma GDP certification

Distributors closely collaborated with stakeholders to anticipate changes and mitigate disruptions

Offers the ability to remotely monitor container conditions and cargo around the clock

The strategy is to expand cold chain capabilities to meet the upcoming demand in the wake of Covid-19

New hub operation in Mexico City will provide containers locally

Covid vaccine-capable system can transport products at a controlled temperature between +20°C and -90°C

With more than 1,400 employees, company focuses on development through to commercialization

Aim is to provide pharma firms and others with more transparency in cold chain operations

The agency has been upgrading cold chain equipment in developing countries around the world

Temperature monitoring will protect vaccines from development through distribution

Merck joins Volansi in collaborative effort to use the emerging technology in the healthcare supply chain

The temperature-controlled containers will be introduced across all flights for large pharma shipments

The deal with unnamed large pharmaceutical company reportedly won’t include vaccine transport

Survey results indicate that only 28 percent of the air cargo industry feels well prepared at this point

Agreement delivers quartz vials in secondary packaging to streamline fill-finish operations for early phase drug development

But volume and price dynamics remain volatile and uncertainty remains

Ultralow temperatures require a revision of vaccine distribution technology